Evidence map›Paper›PMID 41806366›Full record

ArticleJMIR medical informatics2026

Bridging Population Patterns and Individual Prediction: Framework for Prospective Multimorbidity Study.

Qianyao Zhang, Runtong Zhang, Weiguang Ma, Butian Zhao, Xiaomin Zhu

Abstract read
In one paragraph

Article in JMIR medical informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qianyao ZhangDepartment of Information Management, School of Economics and Management, Beijing Jiaotong University, No.3 Shangyuancun, Haidian District, Beijing, 100044, China, 86 010 51683854.ORCID http://orcid.org/0000-0002-9293-6759
Runtong ZhangDepartment of Information Management, School of Economics and Management, Beijing Jiaotong University, No.3 Shangyuancun, Haidian District, Beijing, 100044, China, 86 010 51683854.ORCID http://orcid.org/0000-0003-0246-5058
Weiguang MaDepartment of Information Management, School of Economics and Management, Beijing Jiaotong University, No.3 Shangyuancun, Haidian District, Beijing, 100044, China, 86 010 51683854.ORCID http://orcid.org/0009-0009-8890-3848
Butian ZhaoSchool of Management, Beijing University of Chinese Medicine, Beijing, China.ORCID http://orcid.org/0000-0001-9278-6685
Xiaomin ZhuSchool of Mechanical, Electronic and Control Engineering, Beijing Jiaotong University, Beijing, China.ORCID http://orcid.org/0000-0002-5199-0062

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multimorbidity has become a major global public health challenge. However, existing research primarily emphasizes the identification of disease patterns at the population level and lacks the capacity to provide predictive insights into individual future pattern membership. Bridging this gap is crucial for personalized prevention and management. Objective: This study aims to propose an innovative framework that integrates population-level multimorbidity pattern recognition with individual-level predictive modeling, thus advancing multimorbidity research from descriptive analysis to prospective multimorbidity pattern prediction. Methods: Using longitudinal health follow-up data, we first applied latent transition analysis (LTA) to identify temporally stable multimorbidity patterns. These patterns were subsequently transformed into predictive labels to construct a novel deep learning model, CLA-Net (Cross-Lag Attention Network). CLA-Net is designed to predict individual future multimorbidity patterns by leveraging the complementary strengths of Gated Recurrent Units (GRU) and transformer architectures. It introduces a bitemporal directed cross-attention mechanism to simultaneously capture temporal dependencies and complex feature interactions. We compared CLA-Net against several advanced baselines and conducted ablation studies to validate its architectural components. Results: In terms of pattern recognition, the LTA identified 5 clinically meaningful multimorbidity patterns: Cardiometabolic-Multisystem, Hypertension-Arthritis, Respiratory-Musculoskeletal, Metabolic Syndrome, and Gastritis-Arthritis. In terms of prediction, experimental results demonstrated that CLA-Net significantly outperformed all baseline models. CLA-Net achieved an accuracy of 0.8352 (SD 0.0048), a precision of 0.8326 (SD 0.0053), a recall of 0.8312 (SD 0.0056), and an F1-score of 0.8319 (SD 0.0051). Notably, it achieved an area under the curve of 0.9293, surpassing baseline models. Ablation studies confirmed the necessity of the dual-branch architecture and the directed cross-attention mechanism, as removing these components resulted in performance declines ranging from 0.93% to 2.50%. Conclusions: This study extends the scope of LTA beyond descriptive statistical modeling and establishes the scientific value of multimorbidity pattern prediction as an independent research task. By bridging population-level insights with individual-level prediction, the proposed framework provides a data-driven tool for the prospective prediction of future multimorbidity pattern membership conditional on survival, thereby supporting stratified disease management and care planning, rather than general risk stratification for acute or end-stage deterioration. This offers new methodological and practical value for precision medicine and public health policymaking.

Indexed as

MultimorbidityDeep LearningHumansLongitudinal StudiesPrediction AlgorithmsPredictive Learning ModelsProspective Studiesdeep learninglatent transition analysisLTAmultimorbiditypersonalized medicinepopulation-level patterns

Identifiers

PMID41806366
PMCPMC12983216

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.